Koninklijke Philips NV
PHG25.020USD
-0.240-0.95%
Handelsschluss 04/29, 16:00（ET）Kurse um 15 Minuten verzögert
23.14BMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Koninklijke Philips NV Unternehmen
Koninklijke Philips NV is a Netherlands-based health technology company. The Company's segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care businesses and Other. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease as well as oral healthcare and mother and child care support. The Diagnosis & Treatment businesses segment delivers precision medicine and treatment, and therapy. The Connected Care businesses segment provides consumers, care givers and clinicians with digital solutions that facilitate care by enabling precision medicine and population health management. The Other segment comprises such items, as innovation, emerging businesses, royalties, among others.
Unternehmensinformationen
Unternehmens-codePHG
Name des UnternehmensKoninklijke Philips NV
IPO-datumSep 18, 2009
Gegründet am2000
CEOMr. Roy Jakobs
Anzahl der mitarbeiter67823
WertpapierartOrdinary Share
GeschäftsjahresendeSep 18
AddresseHigh Tech Campus 5
StadtEINDHOVEN
BörseThe Stock Exchange of Thailand
LandNetherlands
Postleitzahl5656 AE
Telefon31205977777
Websitehttps://www.philips.com/
Unternehmens-codePHG
IPO-datumSep 18, 2009
Gegründet am2000
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Steve C. De Baca
Mr. Steve C. De Baca
Executive Vice President, Chief Patient Safety and Quality Officer
Executive Vice President, Chief Patient Safety and Quality Officer
--
--
Mr. Benoit Ribadeau-Dumas
Mr. Benoit Ribadeau-Dumas
Member of the Supervisory Board
Member of the Supervisory Board
--
--
Mr. David E. I. Pyott, CBE
Mr. David E. I. Pyott, CBE
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Ms. Jie Xue
Ms. Jie Xue
Executive Vice President, Chief Business Leader Precision Diagnosis
Executive Vice President, Chief Business Leader Precision Diagnosis
--
--
Ms. M. Elizabeth (Liz) Doherty
Ms. M. Elizabeth (Liz) Doherty
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Bert Van Meurs
Mr. Bert Van Meurs
Executive Vice President, Chief Business Leader - Image Guided Therapy
Executive Vice President, Chief Business Leader - Image Guided Therapy
--
--
Ms. Julia Strandberg
Ms. Julia Strandberg
Executive Vice President, Chief Business Leader Connected Care
Executive Vice President, Chief Business Leader Connected Care
--
--
Ms. Ozlem Duzen Fidanci
Ms. Ozlem Duzen Fidanci
Executive Vice President, Chief of International Region and Leader Growth Region
Executive Vice President, Chief of International Region and Leader Growth Region
--
--
Ms. Liu Ling
Ms. Liu Ling
Executive Vice President, Chief Region Leader of Philips Greater China
Executive Vice President, Chief Region Leader of Philips Greater China
--
--
Mr. A. Marc Harrison
Mr. A. Marc Harrison
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Steve C. De Baca
Mr. Steve C. De Baca
Executive Vice President, Chief Patient Safety and Quality Officer
Executive Vice President, Chief Patient Safety and Quality Officer
--
--
Mr. Benoit Ribadeau-Dumas
Mr. Benoit Ribadeau-Dumas
Member of the Supervisory Board
Member of the Supervisory Board
--
--
Mr. David E. I. Pyott, CBE
Mr. David E. I. Pyott, CBE
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Ms. Jie Xue
Ms. Jie Xue
Executive Vice President, Chief Business Leader Precision Diagnosis
Executive Vice President, Chief Business Leader Precision Diagnosis
--
--
Ms. M. Elizabeth (Liz) Doherty
Ms. M. Elizabeth (Liz) Doherty
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Bert Van Meurs
Mr. Bert Van Meurs
Executive Vice President, Chief Business Leader - Image Guided Therapy
Executive Vice President, Chief Business Leader - Image Guided Therapy
--
--
Umsatzaufteilung
Währung: USDUpdate-Zeit: Sun, Apr 6
Währung: USDUpdate-Zeit: Sun, Apr 6
FY2024
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Keine Daten
Nach RegionUSD
Name
Umsatz
Anteil
United States
7.82B
40.10%
Other Countries
6.05B
31.05%
Netherlands
2.71B
13.91%
China
1.25B
6.40%
Japan
958.28M
4.92%
Germany
706.27M
3.62%
Nach Geschäftsbereich
Nach Region
Keine Daten
Aktionäre
Update-Zeit: Fri, Mar 28
Update-Zeit: Fri, Mar 28
Aktionärsstatistik
Art
Aktionärsstatistik
Aktionäre
Anteil
Mondrian Investment Partners Ltd.
0.77%
Fiduciary Management, Inc.
0.67%
Fidelity Management & Research Company LLC
0.59%
Dimensional Fund Advisors, L.P.
0.46%
BlackRock Investment Management, LLC
0.26%
Other
97.25%
Aktionärsstatistik
Aktionäre
Anteil
Mondrian Investment Partners Ltd.
0.77%
Fiduciary Management, Inc.
0.67%
Fidelity Management & Research Company LLC
0.59%
Dimensional Fund Advisors, L.P.
0.46%
BlackRock Investment Management, LLC
0.26%
Other
97.25%
Art
Aktionäre
Anteil
Investment Advisor
4.33%
Investment Advisor/Hedge Fund
1.47%
Research Firm
0.28%
Hedge Fund
0.17%
Bank and Trust
0.07%
Family Office
0.05%
Family Office
0.04%
Family Office
0.04%
Other
93.56%
Institutionelle Beteiligung
Update-Zeit: Mon, Jan 20
Update-Zeit: Mon, Jan 20
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q1
559
59.05M
6.38%
-13.12M
2024Q4
583
60.06M
6.49%
-29.02M
2024Q3
590
63.64M
6.83%
-28.01M
2024Q2
594
65.28M
6.99%
-29.22M
2024Q1
610
73.19M
7.82%
-21.31M
2023Q4
642
73.00M
7.79%
-18.85M
2023Q3
666
68.56M
7.24%
-21.16M
2023Q2
676
66.71M
7.01%
-36.31M
2023Q1
689
68.47M
7.19%
-38.94M
2022Q4
703
88.43M
9.29%
-24.60M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Mondrian Investment Partners Ltd.
7.14M
0.77%
-759.34K
-9.62%
Dec 31, 2024
Fiduciary Management, Inc.
6.18M
0.67%
-290.89K
-4.50%
Dec 31, 2024
Fidelity Management & Research Company LLC
5.48M
0.59%
-35.58K
-0.65%
Dec 31, 2024
Dimensional Fund Advisors, L.P.
4.29M
0.46%
+85.99K
+2.05%
Dec 31, 2024
BlackRock Investment Management, LLC
2.38M
0.26%
-611.98K
-20.43%
Dec 31, 2024
Connor, Clark & Lunn Investment Management Ltd.
2.22M
0.24%
+1.04M
+87.71%
Dec 31, 2024
Parametric Portfolio Associates LLC
1.74M
0.19%
-71.06K
-3.91%
Dec 31, 2024
Causeway Capital Management LLC
1.57M
0.17%
+303.43K
+24.02%
Dec 31, 2024
Northern Trust Global Investments
1.36M
0.15%
+259.57K
+23.61%
Dec 31, 2024
Thompson, Siegel & Walmsley LLC
1.32M
0.14%
-355.67K
-21.18%
Dec 31, 2024
Mehr Anzeigen
Verbundene ETFs
Update-Zeit: Sun, Apr 6
Update-Zeit: Sun, Apr 6
Name
Anteil
Langar Global HealthTech ETF
5.58%
Brandes International ETF
1.64%
Brandes US Small-Mid Cap Value ETF
1.32%
ActivePassive International Equity ETF
0.34%
DFA Dimensional Intl Sustainability Core 1 ETF
0.2%
Avantis International Large Cap Value ETF
0.2%
Avantis Responsible International Equity ETF
0.15%
SPDR S&P Kensho New Economies Composite ETF
0.14%
Avantis International Equity ETF
0.11%
DFA Dimensional International Core Equity 2 ETF
0.1%
Mehr Anzeigen
Langar Global HealthTech ETF
Anteil5.58%
Brandes International ETF
Anteil1.64%
Brandes US Small-Mid Cap Value ETF
Anteil1.32%
ActivePassive International Equity ETF
Anteil0.34%
DFA Dimensional Intl Sustainability Core 1 ETF
Anteil0.2%
Avantis International Large Cap Value ETF
Anteil0.2%
Avantis Responsible International Equity ETF
Anteil0.15%
SPDR S&P Kensho New Economies Composite ETF
Anteil0.14%
Avantis International Equity ETF
Anteil0.11%
DFA Dimensional International Core Equity 2 ETF
Anteil0.1%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten